医学研究生学报
醫學研究生學報
의학연구생학보
JOURNAL OF MEDICAL POSTGRADUATE
2015年
1期
7-10
,共4页
白杨%李录%马力天%张毅%毛立挺%马瑞%任秦有%胡月%邢劲松%郑瑾
白楊%李錄%馬力天%張毅%毛立挺%馬瑞%任秦有%鬍月%邢勁鬆%鄭瑾
백양%리록%마력천%장의%모립정%마서%임진유%호월%형경송%정근
β-榄香烯%培美曲塞%HeLa细胞%增殖%凋亡
β-欖香烯%培美麯塞%HeLa細胞%增殖%凋亡
β-람향희%배미곡새%HeLa세포%증식%조망
β-elemene%Pemetrexed%HeLa cell%Proliferation%Apoptosis
目的:培美曲塞和β-榄香烯均可抑制肿瘤细胞的生长。文中探讨培美曲塞联合β-榄香烯对宫颈癌HeLa细胞增殖和凋亡的影响。方法体外培养宫颈癌HeLa细胞,将培美曲塞(浓度为38、76、152、228、304μg/mL)单独作用于HeLa细胞后24、48 h用MTT比色法检测细胞的增殖情况,实验分β-榄香烯组(125μg/mL )、培美曲塞组(76μg/mL )、联合用药组(培美曲塞76μg/mL,β-榄香烯125μg/mL)及空白对照组(0μg/mL),24 h后用MTT法检测细胞的增殖情况,用流式细胞术检测24 h细胞的凋亡率。结果 MTT法显示,培美曲塞浓度在38、76、152、228、304μg/mL梯度范围内对HeLa细胞有抑制作用,随浓度增加,抑制率增强。38、76、152、228、304μg/mL的培美曲塞作用24后,增殖抑制率分别为(7.24±3.78)%、(7.94±4.37)%、(11.10±2.86)%、(15.88±3.38)%、(16.52±2.54)%;其中38、76、152、228μg/mL培美曲塞抑制率两两比较的差异有统计学意义(P<0.05)。联合用药组24 h抑制率[(49.95±5.76)%]高于β-榄香烯组[(24.36±5.59)%]和培美曲塞组[(10.69±1.37)%],差异有统计学意义(P<0.01)。结论培美曲塞与β-榄香烯联合应用可抑制HeLa细胞的增殖,协同促进HeLa细胞的凋亡。
目的:培美麯塞和β-欖香烯均可抑製腫瘤細胞的生長。文中探討培美麯塞聯閤β-欖香烯對宮頸癌HeLa細胞增殖和凋亡的影響。方法體外培養宮頸癌HeLa細胞,將培美麯塞(濃度為38、76、152、228、304μg/mL)單獨作用于HeLa細胞後24、48 h用MTT比色法檢測細胞的增殖情況,實驗分β-欖香烯組(125μg/mL )、培美麯塞組(76μg/mL )、聯閤用藥組(培美麯塞76μg/mL,β-欖香烯125μg/mL)及空白對照組(0μg/mL),24 h後用MTT法檢測細胞的增殖情況,用流式細胞術檢測24 h細胞的凋亡率。結果 MTT法顯示,培美麯塞濃度在38、76、152、228、304μg/mL梯度範圍內對HeLa細胞有抑製作用,隨濃度增加,抑製率增彊。38、76、152、228、304μg/mL的培美麯塞作用24後,增殖抑製率分彆為(7.24±3.78)%、(7.94±4.37)%、(11.10±2.86)%、(15.88±3.38)%、(16.52±2.54)%;其中38、76、152、228μg/mL培美麯塞抑製率兩兩比較的差異有統計學意義(P<0.05)。聯閤用藥組24 h抑製率[(49.95±5.76)%]高于β-欖香烯組[(24.36±5.59)%]和培美麯塞組[(10.69±1.37)%],差異有統計學意義(P<0.01)。結論培美麯塞與β-欖香烯聯閤應用可抑製HeLa細胞的增殖,協同促進HeLa細胞的凋亡。
목적:배미곡새화β-람향희균가억제종류세포적생장。문중탐토배미곡새연합β-람향희대궁경암HeLa세포증식화조망적영향。방법체외배양궁경암HeLa세포,장배미곡새(농도위38、76、152、228、304μg/mL)단독작용우HeLa세포후24、48 h용MTT비색법검측세포적증식정황,실험분β-람향희조(125μg/mL )、배미곡새조(76μg/mL )、연합용약조(배미곡새76μg/mL,β-람향희125μg/mL)급공백대조조(0μg/mL),24 h후용MTT법검측세포적증식정황,용류식세포술검측24 h세포적조망솔。결과 MTT법현시,배미곡새농도재38、76、152、228、304μg/mL제도범위내대HeLa세포유억제작용,수농도증가,억제솔증강。38、76、152、228、304μg/mL적배미곡새작용24후,증식억제솔분별위(7.24±3.78)%、(7.94±4.37)%、(11.10±2.86)%、(15.88±3.38)%、(16.52±2.54)%;기중38、76、152、228μg/mL배미곡새억제솔량량비교적차이유통계학의의(P<0.05)。연합용약조24 h억제솔[(49.95±5.76)%]고우β-람향희조[(24.36±5.59)%]화배미곡새조[(10.69±1.37)%],차이유통계학의의(P<0.01)。결론배미곡새여β-람향희연합응용가억제HeLa세포적증식,협동촉진HeLa세포적조망。
Objective Pemetrexed and β-elemene can inhibit the growth of tumor cells .This study was to investigate the effect of pemetrexed combined with β-elemene on the proliferation and apoptosis of cervical cancer HeLa cells. Methods Cervical cancer HeLa cells were treated with pemetrexed at the concentrations of 38, 76, 152, 228, and 304μg/mL, and at 24 and 48 hours of treatment subjected to MTT for detection of their proliferation .The experiment included four groups , with the cells treated with β-elemene ( 125μg/mL) , pemetrexed ( 76 μg/mL ) , β-elemene ( 125 μg/mL ) +pemetrexed (76μg/mL), and nothing (blank control) for 24 hours, followed by determination of their proliferation and apoptosis by MTT and flow cytometry, respectively. Results Pemetrexed at 38, 76, 152 and 228μg/mL inhibited the proliferation of the HeLa cells in a concentration-dependent manner, with the inhibition rates of (7.24 ±3.78), (7.94 ±4.37), (11.10 ±2.86) and (15.88 ± 3.38)%at 24 hours, and (16.69 ±0.95), (22.54 ±1.53), (24.48 ±0.92) and (25.54 ±3.61)%at 48 hours, both with statis-tically significant differences between any two groups (P<0.05).Significant differences were also found in the proliferation rate of the same concentration of pemetrexed at the two time points (P<0.05).The combination of pemetrexed and β-elemene showed an inhibi-tion rate of (49.95 ±5.76)%at 24 hours, remarkably higher than (24.36 ±5.59)%in theβ-elemene group and (10.69 ±1.37)%in the pemetrexed group (P<0.01). Conclusion Pemetrexed combined with β-elemene can significantly inhibit the proliferation and synergistically accelerate the apoptosis of HeLa cells .